Newsfile
Search documents
ROSEN, LEADING TRIAL ATTORNEYS, Encourages CarMax, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - KMX
Newsfile· 2025-11-13 21:47
Core Viewpoint - Rosen Law Firm is encouraging investors of CarMax, Inc. to secure legal counsel before the January 2, 2026 deadline for a securities class action lawsuit related to the company's misleading statements during the class period from June 20, 2025, to November 5, 2025 [2][6]. Group 1: Class Action Details - Investors who purchased CarMax securities during the specified class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by January 2, 2026 [4]. - The lawsuit alleges that CarMax's management made materially false and misleading statements regarding the company's growth prospects, which were based on temporary market conditions rather than sustainable business performance [6]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [5]. - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions of dollars for investors [5]. - In 2019, the firm secured over $438 million for investors, showcasing its capability and success in representing clients in securities litigation [5].
Nio Strategic Metals Announces Grants of Stock Options
Newsfile· 2025-11-13 21:31
Core Points - Nio Strategic Metals Inc. has granted incentive stock options to its officers and directors, allowing the purchase of up to 1,800,000 common shares at a price of CA$0.15 per share, expiring on October 13, 2030 [1] - The company focuses on becoming a ferroniobium producer and holds niobium properties in Oka and near Mont-Laurier, as well as another exploration property in Quebec [2] Company Overview - Nio Strategic Metals is an exploration and development company specializing in critical minerals, particularly niobium [2] - The company is publicly listed on the TSX Venture Exchange under the ticker NIO and on the OTC Pink under NIOCF [1][2]
K9 Gold Corp. Announces Name Change to Americore Resources Corp
Newsfile· 2025-11-13 21:30
Vancouver, British Columbia--(Newsfile Corp. - November 13, 2025) - K9 Gold Corp. (TSXV: KNC) (OTCQB: WDFCF) (FSE: 5GP0) ("K9 Gold" or the "Company is pleased to announce that, effective November 18, 2025, the Company will change its name from K9 Gold Corp. to Americore Resources Corp.Effective at the opening of trading on November 18, 2025, the common shares of the Company will commence trading on the TSX Venture Exchange under the new name and the new trading symbol "AMCO". The Company's new CUSIP number ...
Palamina Announces Extension of Private Placement
Newsfile· 2025-11-13 21:30
Core Points - Palamina Corp. has closed the first tranche of its non-brokered private placement offering and is seeking a 30-day extension for price protection until December 12, 2025, to complete additional subscriptions totaling up to $865,625 [1] - The offering is subject to regulatory approvals and the receipt of subscriptions [1] - Palamina is an exploration company with high-grade copper-silver assets in Peru and gold projects in the Puno Orogenic Gold Belt, trading on TSX Venture Exchange under the symbol PA and on OTCQB under PLMNF [3]
Stonegate Capital Partners Initiates Coverage on Fold Holdings Inc. (FLD)
Newsfile· 2025-11-13 21:23
Core Insights - Stonegate Capital Partners has initiated coverage on Fold Holdings Inc. (NASDAQ: FLD) highlighting its strong financial performance and growth momentum [1] Financial Performance - Fold Holdings reported revenue of $7.4 million, representing a 41% year-over-year increase, with a net income of $0.6 million [1][7] - The company achieved a total transaction volume of $265 million for the quarter, with over 10,000 net new accounts and more than 3,000 new verified accounts [1] - As of Q3 2025, new accounts increased by 2.1% year-over-year, while transaction volumes rose approximately 41% year-over-year [1] Growth and Operational Efficiency - The company maintained nearly 50% top-line growth compared to the previous year, with expectations for continued strong growth into Q4 [1] - Management noted that headcount has roughly doubled year-over-year while maintaining margins, indicating early operating leverage [1] - The quarter demonstrated improving operating leverage with focused spending on distribution and product [1] Product Development and Market Expansion - Product momentum is evident as the Visa and Stripe credit card approaches launch, with a waitlist exceeding 75,000 [7] - The Bitcoin Gift Card is expanding to approximately 2,000 Kroger locations, supported by a promotion with Steak 'n Shake [7] - The company has strengthened its liquidity with a new $45 million revolving credit facility, alongside an existing $250 million equity facility and a treasury of 1,526 BTC [7]
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - TLX
Newsfile· 2025-11-13 21:17
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - TLXNovember 13, 2025 4:17 PM EST | Source: The Rosen Law Firm PANew York, New York--(Newsfile Corp. - November 13, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) between Febru ...
Phio Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
Newsfile· 2025-11-13 21:15
Core Insights - Phio Pharmaceuticals reported positive clinical trial results for its lead compound PH-762, achieving 100% tumor clearance in one patient and over 90% clearance in another patient in the fifth cohort of its Phase 1b trial [1][2][3] - The company secured approximately $12.1 million in net proceeds from warrant inducement financing, extending its cash runway into the first half of 2027 [1][9] - Financial results for Q3 2025 showed a net loss of $2.4 million, an increase from $1.5 million in Q3 2024, primarily due to higher research and development expenses [1][13] Clinical Trial Progress - The ongoing Phase 1b trial is evaluating the safety and tolerability of PH-762 in patients with various stages of cutaneous squamous cell carcinoma, melanoma, and Merkel cell carcinoma [2][15] - As of now, 18 patients have completed treatment across five cohorts, with cumulative results indicating six complete responses and two near-complete responses among patients with cutaneous squamous cell carcinoma [3][4] Financial Overview - As of September 30, 2025, the company had cash and cash equivalents of approximately $10.7 million, up from $5.4 million at the end of 2024, with an estimated total of $21.3 million post-financing [10][20] - Research and development expenses for Q3 2025 were $1.2 million, compared to $0.6 million in the same period of 2024, driven by increased clinical trial costs [11] - General and administrative expenses rose to $1.3 million in Q3 2025 from $0.9 million in Q3 2024, attributed to higher professional fees and employee stock compensation [12] Business Developments - The company entered into a drug substance development services agreement with a U.S. manufacturer for the cGMP production of clinical supplies for PH-762 in July 2025 [5] - Phio has actively engaged in scientific and investor presentations to showcase its INTASYL technology and clinical trial results [7]
MultiSensor AI Announces Third Quarter 2025 Results
Newsfile· 2025-11-13 21:15
Core Insights - MultiSensor AI Holdings, Inc. reported financial results for Q3 2025, highlighting progress in operational excellence and growth initiatives [1][2] - The company is focused on enhancing its recurring revenue base and transitioning to integrated, solution-oriented offerings [2] Financial Highlights - Q3 2025 revenue was $1.6 million, consistent with Q3 2024, and increased by $0.2 million, or 11%, quarter over quarter [7] - Software revenue reached $0.6 million, marking a 114% increase compared to Q3 2024 and a 54% increase quarter over quarter [7] - Gross margin was 64%, a decrease of 3% year over year but an increase of 40% quarter over quarter [7] - The net loss for Q3 2025 was $1.7 million, down by $6.5 million, or 80%, year over year, and down by $1.6 million, or 50%, quarter over quarter [7] Strategic Business Highlights - The company has realigned its solutions into two offerings: Early Threat Detection (ETD) and Reliability Maintenance Engineering (RME) [7] - MSAI launched the MSAI Hub, an edge gateway designed to simplify installation [7] - The company is focusing on the Data Center market, particularly on Electrical Panel Monitoring (EPM) and ETD applications [7] - As of September 30, 2025, approximately 665 active sensors were connected to the MSAI Connect platform, a 9% increase quarter over quarter and a 167% increase year over year [7]
Stonegate Capital Partners Updates Coverage On Surf Air Mobility Inc. (SRFM) 2025 Q3
Newsfile· 2025-11-13 21:11
Core Insights - Surf Air Mobility Inc. (SRFM) reported Q3 2025 revenue of $29.2 million, reflecting a 6% sequential growth and a 3% year-over-year increase, driven by a 42% rise in On Demand services [5] - The company experienced an adjusted EBITDA loss of $9.9 million, which was in line with guidance, while airline operations achieved a second consecutive quarter of positive adjusted EBITDA [5] - Significant capital structure improvements were made, including a $100 million strategic transaction to fund SurfOS and refinance debt, positioning the company for a more sustainable capital structure [5] Financial Performance - Revenue for Q3 2025 was $29.2 million, exceeding guidance [5] - Adjusted EBITDA loss was reported at $9.9 million, consistent with expectations [5] - The airline operations segment delivered positive adjusted EBITDA for the second consecutive quarter [5] Strategic Developments - The company has made substantial improvements to its capital structure, refinancing higher-cost debt and reducing annual cash interest [5] - These actions are expected to provide a clearer path toward scaling operations and initiating Phase 3 of the transformation plan in FY26 [5]
Stonegate Capital Partners Updates Coverage on Sky Harbour Group Corporation (SKYH) Q3 2025
Newsfile· 2025-11-13 21:11
Core Insights - Sky Harbour Group Corp. (NYSE: SKYH) demonstrated strong momentum in Q3 2025, transitioning from development to cash-generating operations [1] - The company is now conducting resident flight operations at nine campuses, with additional Tier 1 locations in development [1] - Constructed assets and construction in progress exceeded $308 million at the end of the quarter, indicating significant growth [1] Financial Performance - Revenue reached $7.3 million, reflecting a 78% year-over-year increase and an 11% sequential increase, driven by $5.7 million in rental income and $1.6 million from fuel as nine campuses ramped up operations [6] - At the end of Q3 2025, liquidity stood at approximately $48 million in cash, restricted cash, and Treasuries, with a new $200 million warehouse facility available for expansion to $300 million, which remained undrawn [6] Operational Developments - The company has fully operational sites at Sugar Land, Nashville, Miami Opa-Locka, San Jose, Camarillo, Phoenix Deer Valley, Dallas Addison, Seattle Boeing Field, and Denver Centennial [1] - Management has strengthened the capital structure by signing a joint venture letter of intent for an SH34 hangar at OPF Phase 2, providing flexible and lower-cost funding for future growth [1]